Facebook Linkedin RSS Twitter Youtube
Home 2024

Immunosuppressive therapy

Endpoints: Critical Preclinical Markers in Extracellular Protein Degradation Assays
Cancer

Endpoints: Critical Preclinical Markers in Extracellular Protein Degradation Assays

Immunosuppressant Ruxolitinib Boosts Checkpoint Inhibitor Response in Patients with Hodgkin Lymphoma, Phase I Data Show
Cancer

Immunosuppressant Ruxolitinib Boosts Checkpoint Inhibitor Response in Patients with Hodgkin Lymphoma, Phase I Data Show

Phage Therapy Temporarily Held Recurrent Enterococcal Infection at Bay
Infectious Diseases

Phage Therapy Temporarily Held Recurrent Enterococcal Infection at Bay

Genetically Engineered Protein Boosts Memory in Animal Models
News

Genetically Engineered Protein Boosts Memory in Animal Models

Chromatin Architecture of Treg Cells May Offer Target for Immunosuppressive Therapies
Featured

Chromatin Architecture of Treg Cells May Offer Target for Immunosuppressive Therapies

Locks on Translation Initiation May Restrain Cancer
Cancer

Locks on Translation Initiation May Restrain Cancer

New Tools in the Host Cell Protein Analysis Toolbox
Bioprocessing

New Tools in the Host Cell Protein Analysis Toolbox

Antibody Prevents Gastrointestinal GVHD without Broad Immunosuppression
Cancer

Antibody Prevents Gastrointestinal GVHD without Broad Immunosuppression

Monocytes May Be a Stable Reservoir of HIV
Infectious Diseases

Monocytes May Be a Stable Reservoir of HIV

SARS-CoV-2 Cell Surface Nucleocapsid Protein Modulates Innate and Adaptive Host Immunity
Drug Discovery

SARS-CoV-2 Cell Surface Nucleocapsid Protein Modulates Innate and Adaptive Host Immunity

12Page 1 of 2
Copyright © 2024 Genetic Engineering & Biotechnology News. All Rights Reserved.